Quick Answer
Docebo Inc. reported r&d expense of $50.12 million for fiscal year 2025 (IFRS, Form 20-F).
Reported under IFRS (SEC Form 20-F). Figures are shown in USD where the company provided them, otherwise in its reporting currency — each value exactly as filed with the SEC, not converted.
Docebo Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $50.12M | +14.1% |
| 2024 | $43.91M | +23.8% |
| 2023 | $35.48M | +43.2% |
| 2022 | $24.78M | +21.7% |
| 2021 | $20.36M | +52.1% |
| 2020 | $13.38M | +41.8% |
| 2019 | $9.44M | — |
- Docebo Inc.’s r&d expense rose 14.1% year over year.
- The most recent figure is from Docebo Inc.’s fiscal year 2025 annual report (Form 20-F), filed February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 19, 2026.
Last verified: